Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Radiotherapy in the treatment of hereditary breast cancer.

Seminars in radiation oncology - 1 Jan 2011

Pierce Lori J, Haffty Bruce G

Abstract excerpt

Hereditary breast cancer represents approximately 5% to 10% of breast cancers and a larger portion of patients with early-onset disease. Given the relatively recent identification of the BRCA1 and BRCA2 genes, the available literature with respect to outcomes related to radiation therapy has inhe...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to AMP-Activated Protein Kinase Kinases
Share to Ataxia Telangiectasia Mutated Proteins
Share to Checkpoint Kinase 2

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Fanconi Anemia Complementation Group N Protein

Share to Fanconi Anemia Complementation Group Proteins

Share to Li-Fraumeni Syndrome

Share to Mastectomy

Share to RNA Helicases

Source

Identifiers

PMID: 21134653
DOI: 10.1016/j.semradonc.2010.08.008

Genes

BRCA1
BRCA2
ATM
CHEK2
PALB2
PTEN

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-21134653-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Radiotherapy in the treatment of hereditary breast cancer.PMID 21134653Read ↗

Clinical radiosensitivity in breast cancer patients carrying pathogenic ATM gene mutations: no observation of increased radiation-induced acute or late effectsSemantic proximity Read ↗

Radiotherapy for breast cancer in BRCA1/BRCA2 carriers: clinical issues and management dilemmas.Semantic proximity Read ↗

Radiotherapy and genetic predisposition to breast cancer.Semantic proximity Read ↗

Ionizing radiation-induced DNA injury and damage detection in patients with breast cancerSemantic proximity Read ↗

Variants in activators and downstream targets of ATM, radiation exposure, and contralateral breast cancer risk in the WECARE study.Semantic proximity Read ↗

Radiation exposure, the ATM Gene, and contralateral breast cancer in the women's environmental cancer and radiation epidemiology study.Semantic proximity Read ↗

Conservative management of breast cancer in BRCA1/2 mutation carriers.Semantic proximity Read ↗

Clinicopathological Features and Outcomes in Individuals with Breast Cancer and ATM, CHEK2, or PALB2 Mutations.Semantic proximity Read ↗

Association Between Polymorphisms in DNA Damage Repair Genes and Radiation Therapy-Induced Early Adverse Skin Reactions in a Breast Cancer Population: A Polygenic Risk Score Approach.Semantic proximity Read ↗

[Genetic bases of the radiosensitivity of breast cancer].Semantic proximity Read ↗

Radiation Treatment, ATM, BRCA1/2, and CHEK2*1100delC Pathogenic Variants and Risk of Contralateral Breast Cancer.Semantic proximity Read ↗

Workshop on The Epidemiology of the ATM Gene: Impact on Breast Cancer Risk and Treatment, Present Status and Future Focus, Lillehammer, Norway, 29 June 2002.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.